150 related articles for article (PubMed ID: 9012403)
1. A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors.
Cappione AJ; French BL; Skuse GR
Am J Hum Genet; 1997 Feb; 60(2):305-12. PubMed ID: 9012403
[TBL] [Abstract][Full Text] [Related]
2. RNA processing and clinical variability in neurofibromatosis type I (NF1).
Skuse GR; Cappione AJ
Hum Mol Genet; 1997; 6(10):1707-12. PubMed ID: 9300663
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the GAP-related domain of the neurofibromatosis type 1 (NF1) gene in childhood brain tumors.
Scheurlen WG; Senf L
Int J Cancer; 1995 Aug; 64(4):234-8. PubMed ID: 7657385
[TBL] [Abstract][Full Text] [Related]
4. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.
Mukhopadhyay D; Anant S; Lee RM; Kennedy S; Viskochil D; Davidson NO
Am J Hum Genet; 2002 Jan; 70(1):38-50. PubMed ID: 11727199
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.
Menon AG; Anderson KM; Riccardi VM; Chung RY; Whaley JM; Yandell DW; Farmer GE; Freiman RN; Lee JK; Li FP
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5435-9. PubMed ID: 2142531
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
7. The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing.
Skuse GR; Cappione AJ; Sowden M; Metheny LJ; Smith HC
Nucleic Acids Res; 1996 Feb; 24(3):478-85. PubMed ID: 8602361
[TBL] [Abstract][Full Text] [Related]
8. Gene regulation by mRNA editing.
Ashkenas J
Am J Hum Genet; 1997 Feb; 60(2):278-83. PubMed ID: 9012400
[No Abstract] [Full Text] [Related]
9. Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations.
Serra E; Ars E; Ravella A; Sánchez A; Puig S; Rosenbaum T; Estivill X; Lázaro C
Hum Genet; 2001 May; 108(5):416-29. PubMed ID: 11409870
[TBL] [Abstract][Full Text] [Related]
10. [Molecular genetics of neurofibromatosis type 1].
Suzuki H; Takahashi K; Shibahara S
Nihon Rinsho; 1993 Sep; 51(9):2457-61. PubMed ID: 8411728
[TBL] [Abstract][Full Text] [Related]
11. Absence of mutation at the GAP-related domain of the neurofibromatosis type 1 gene in sporadic neurofibrosarcomas and other bone and soft tissue sarcomas.
Gómez L; Barrios C; Kreicbergs A; Zetterberg A; Pestaña A; Castresana JS
Cancer Genet Cytogenet; 1995 Jun; 81(2):173-4. PubMed ID: 7621416
[TBL] [Abstract][Full Text] [Related]
12. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene.
Däschner K; Assum G; Eisenbarth I; Krone W; Hoffmeyer S; Wortmann S; Heymer B; Kehrer-Sawatzki H
Biochem Biophys Res Commun; 1997 May; 234(2):346-50. PubMed ID: 9177273
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of NF1 and OMGP gene transcripts in sporadic gliomas, sporadic meningiomas and neurofibromatosis type 1-associated plexiform neurofibromas.
Peters N; Waha A; Wellenreuther R; Friedrich RE; Mautner VF; Hoffmeyer S; Lenartz D; Schramm J; Wiestler OD; von Deimling A
Acta Neuropathol; 1999 Jun; 97(6):547-51. PubMed ID: 10378372
[TBL] [Abstract][Full Text] [Related]
14. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1.
Rutkowski JL; Wu K; Gutmann DH; Boyer PJ; Legius E
Hum Mol Genet; 2000 Apr; 9(7):1059-66. PubMed ID: 10767330
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing of neurofibromatosis type 1 gene transcript in malignant brain tumors: PCR analysis of frozen-section mRNA.
Mochizuki H; Nishi T; Bruner JM; Lee PS; Levin VA; Saya H
Mol Carcinog; 1992; 6(2):83-7. PubMed ID: 1388685
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation.
Nishi T; Lee PS; Oka K; Levin VA; Tanase S; Morino Y; Saya H
Oncogene; 1991 Sep; 6(9):1555-9. PubMed ID: 1923522
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutations in the neurofibromatosis 1 gene in human tumors.
Li Y; Bollag G; Clark R; Stevens J; Conroy L; Fults D; Ward K; Friedman E; Samowitz W; Robertson M
Cell; 1992 Apr; 69(2):275-81. PubMed ID: 1568247
[TBL] [Abstract][Full Text] [Related]
18. Novel NF1 gene mutation in a Japanese patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor.
Nemoto H; Tate G; Schirinzi A; Suzuki T; Sasaya S; Yoshizawa Y; Midorikawa T; Mitsuya T; Dallapiccola B; Sanada Y
J Gastroenterol; 2006 Apr; 41(4):378-82. PubMed ID: 16741618
[TBL] [Abstract][Full Text] [Related]
19. Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis.
Xu W; Mulligan LM; Ponder MA; Liu L; Smith BA; Mathew CG; Ponder BA
Genes Chromosomes Cancer; 1992 Jun; 4(4):337-42. PubMed ID: 1377942
[TBL] [Abstract][Full Text] [Related]
20. Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas.
Thomas L; Spurlock G; Eudall C; Thomas NS; Mort M; Hamby SE; Chuzhanova N; Brems H; Legius E; Cooper DN; Upadhyaya M
Eur J Hum Genet; 2012 Apr; 20(4):411-9. PubMed ID: 22108604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
